Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Comparison of efficacy and prognostic factors in elderly acute myelogenous patients with MA or CAG induction chemotherapy regimen].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 1 Mar 2016

Wang J, Jiang B, Jiang Q, Lu J, Zhu H H, Yang S M, Zhao T, Wen L, Bao L, Huang X J, Jiang H

Abstract excerpt

OBJECTIVE: To analyze the difference of efficacy and prognostic factors between MA and CAG induction chemotherapy in elderly acute myelogenous leukemia (AML) patients. METHODS: From April 2009 to September 2015, 103 consecutive hospitalized 60-plus-year-old AML patients were retrospectively analyzed. NPM1 positive FLT3-ITD negative accounted for 17 cases (16.7%). Sixty-five patients received MA regimen and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Cytarabine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Granulocyte Colony-Stimulating Factor

Share to Induction Chemotherapy

Share to Nucleophosmin

Share to Remission Induction

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 27033755
DOI: 10.3760/cma.j.issn.0253-2727.2016.03.004
PMCID: PMC7342949

Genes

FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Comparison of efficacy and prognostic factors in elderly acute myelogenous patients with MA or CAG induction chemotherapy regimen].PMID 27033755Read ↗

[Molecular Features and Clinical Significance of Acute Myeloid Leukemia in Elderly Patients].Semantic proximity Read ↗

[Outcomes of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia patients followed the therapy including decitabine combined with CAG or CAG-like regimen].Semantic proximity Read ↗

[Correlation of MiR-34a/b/c Expression with Treatment Response and Prognosis of Elderly Patients with Acute Myeloid Leukemia].Semantic proximity Read ↗

[Research Advances on Targeted Therapy for Acute Myeloid Leukemia--Review].Semantic proximity Read ↗

[Efficacy and Safety of Decitabine Combined with Modified CAG Regimen in Patients Aged ≥ 70 Years with Newly Diagnosed Acute Myeloid Leukemia].Semantic proximity Read ↗

[Coexisting mutations in NPM1-mutated elderly adults with acute myeloid leukemia].Semantic proximity Read ↗

Venetoclax and Azacitidine Therapy in Elder Acute Myeloid Leukemia: A Retrospective Evaluation of Real-World ExperienceSemantic proximity Read ↗

[Cytotoxic chemotherapy for AML in adults].Semantic proximity Read ↗

[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia].Semantic proximity Read ↗

[Outcome of acute myeloid leukemia with FLT3-ITD mutation treated by allogeneic hematopoietic stem cell transplantation].Semantic proximity Read ↗

[Stratified treatment of fit and unfit acute myeloid leukemia].Semantic proximity Read ↗

[Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Treatment of Intermediate Risk Acute Myeloid Leukemia with Negative for FLT3-ITD, NPM1 or Biallelic CEBPA Mutation].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.